Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin

被引:27
作者
Picard, V
Marque, PE
Paolucci, F
Aiach, M
Le Bonniec, BF
机构
[1] Univ Paris 05, Fac Pharm, INSERM, U428, F-75270 Paris 06, France
[2] Sanofi Res, F-34000 Montpellier, France
关键词
D O I
10.1074/jbc.274.8.4586
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Solving the structure of the stable complex between a serine protease inhibitor (serpin) and its target has been a long standing goal. We describe herein the characterization of a monoclonal antibody that selectively recognizes antithrombin in complex with either thrombin, factor Xa, or a synthetic peptide corresponding to residues P-14 to P-9 of the serpin's reactive center loop (RCL, ultimately cleaved between the P-1 and P'(1) residues), Accordingly, this antibody reacts with none of the monomeric conformers of antithrombin (native, latent, and RCL-cleaved) and does not recognize heparin-activated antithrombin or antithrombin bound to a non-catalytic mutant of thrombin (S195A, in which the serine of the charge stabilizing system has been swapped for alanine). The neoepitope encompasses the motif DAFHX, located in native antithrombin on strand 4 of beta-sheet A, which becomes strand 5 of beta-sheet A in the RCL-cleaved and latent conformers. The inferences on the structure of the antithrombin-protease stable complex are that either a major remodeling of antithrombin accompanies the final elaboration of the complex or that, within the complex, at the most residues P-14 to P-9 of the RCL are inserted into beta-sheet A. These conclusions limit drastically the possible locations of the defeated protease within the complex.
引用
收藏
页码:4586 / 4593
页数:8
相关论文
共 63 条
  • [1] ASAKURA S, 1990, J BIOL CHEM, V265, P5135
  • [2] CRYSTAL-STRUCTURE OF CLEAVED HUMAN ALPHA-1-ANTICHYMOTRYPSIN AT 2.7-A RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
    BAUMANN, U
    HUBER, R
    BODE, W
    GROSSE, D
    LESJAK, M
    LAURELL, CB
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (03) : 595 - 606
  • [3] CRYSTAL-STRUCTURE OF CLEAVED EQUINE LEUKOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95-ANGSTROM RESOLUTION
    BAUMANN, U
    BODE, W
    HUBER, R
    TRAVIS, J
    POTEMPA, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1992, 226 (04) : 1207 - 1218
  • [4] BJORK I, 1992, J BIOL CHEM, V267, P1976
  • [5] BJORK I, 1992, J BIOL CHEM, V267, P19047
  • [6] BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501
  • [7] THROMBOEMBOLIC DISEASE DUE TO THERMOLABILE CONFORMATIONAL-CHANGES OF ANTITHROMBIN ROUEN-VI (187-ASN-]ASP)
    BRUCE, D
    PERRY, DJ
    BORG, JY
    CARRELL, RW
    WARDELL, MR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) : 2265 - 2274
  • [8] BIOLOGICAL IMPLICATIONS OF A 3-ANGSTROM STRUCTURE OF DIMERIC ANTITHROMBIN
    CARRELL, RW
    STEIN, PE
    WARDELL, MR
    FERMI, G
    [J]. STRUCTURE, 1994, 2 (04) : 257 - 270
  • [9] Chang WSW, 1997, PROTEIN SCI, V6, P89
  • [10] CHARACTERIZATION OF COMMON NEOANTIGENIC EPITOPES GENERATED IN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AFTER CLEAVAGE OF THE REACTIVE CENTER LOOP OR AFTER COMPLEX-FORMATION WITH VARIOUS SERINE PROTEINASES
    DEBROCK, S
    DECLERCK, PJ
    [J]. FEBS LETTERS, 1995, 376 (03) : 243 - 246